about
Genetics and biology of pancreatic ductal adenocarcinomaUbiquitin-dependent regulation of Foxp3 and Treg functionUpdate on the challenges and recent advances in cancer immunotherapyThe Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the LungT Helper Lymphocyte Subsets and Plasticity in Autoimmunity and Cancer: An OverviewEnhanced antitumor immunity contributes to the radio-sensitization of ehrlich ascites tumor by the glycolytic inhibitor 2-deoxy-D-glucose in micep38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression.Ubiquitin ligase A20 regulates p53 protein in human colon epithelial cells.CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells.Fully human antagonistic antibodies against CCR4 potently inhibit cell signaling and chemotaxis.Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment.Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study.Immune system phenotyping of radiation and radiation combined injury in outbred miceNon-viral immune electrogene therapy induces potent antitumour responses and has a curative effect in murine colon adenocarcinoma and melanoma cancer modelsDepletion of CD4+ CD25+ regulatory T cells promotes CCL21-mediated antitumor immunitySuppression of Tregs by anti-glucocorticoid induced TNF receptor antibody enhances the antitumor immunity of interferon-α gene therapy for pancreatic cancer.Chemokines and their receptors play important roles in the development of hepatocellular carcinomaCD4(+)CD25(-)Foxp3(+) T cells play a role in tuberculous hydrothorax rather than malignant hydrothorax.Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma.Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathologyImpaired T-bet-pSTAT1α and perforin-mediated immune responses in the tumoral region of lung adenocarcinoma.Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy.Hypoxia-inducible factors in T lymphocyte differentiation and function. A Review in the Theme: Cellular Responses to HypoxiaTh2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma.Humanization of an anti-CCR4 antibody that kills cutaneous T-cell lymphoma cells and abrogates suppression by T-regulatory cellsRepurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agentCancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator-activated receptor α.Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?TIM3(+)FOXP3(+) regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer.Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell CarcinomaDepleting tumor-specific Tregs at a single site eradicates disseminated tumors.Clinical significance of T-bet, GATA-3, and Bcl-6 transcription factor expression in bladder carcinoma.Inhibition of lung metastasis by chemokine CCL17-mediated in vivo silencing of genes in CCR4+ Tregs.Cancer as an immune-mediated disease.Maraviroc decreases CCL8-mediated migration of CCR5(+) regulatory T cells and reduces metastatic tumor growth in the lungs.CCR7 expression and intratumoral FOXP3+ regulatory T cells are correlated with overall survival and lymph node metastasis in gastric cancer.Pathogen-specific Treg cells expand early during mycobacterium tuberculosis infection but are later eliminated in response to Interleukin-12.Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists.Combination of SLC administration and Tregs depletion is an attractive strategy for targeting hepatocellular carcinomaRole of tumor microenvironment in tumorigenesis.
P2860
Q26765438-DD7AE132-DD43-449B-8C2E-11421E6E2DF2Q26863525-FFAB200E-1434-494A-A924-BC138AFC0B1BQ27014693-71A07C1B-E1EC-45A2-B3BF-9734F6ECFCC2Q28070412-504E3C65-8ED2-4DE8-BA7A-920022BBC281Q28081582-360E69B4-2C9D-40E9-B059-6179654B60A2Q28543176-0C42208C-8262-4D99-8CD2-72CB0D890114Q30422500-AA913843-72A1-4332-AA06-13DF3CB73B03Q33611907-D0C57E04-9B3B-4B14-B826-E094186A1FB0Q33808334-EE6E8FB2-F3BE-4F21-B86F-C364DBE51412Q33982582-E6D98C26-0B53-43B6-9244-D04EC40CCBC8Q34502899-1700731F-D433-43C7-8BB5-31FE84F72FA8Q34718331-AC5103AA-7AC7-46A6-BA96-6B45925858F8Q34870908-4D2993C2-BC7A-4B98-A111-427ECE78DB6CQ34904172-5859A65B-7E3F-4EE7-8FAF-EDFE57B1743BQ34984596-40305ADE-666E-457F-BFE8-966C838BEC7AQ35051508-9E7187AB-63C1-4EDE-ABC9-21001ADAA74AQ35668771-6CEA9316-92A9-40ED-8D5D-45E9113DA160Q35964725-B4E8167E-86AE-4480-B48D-933328D01685Q36015463-08987DB5-6900-49AB-A3E1-F6D3C623EF79Q36018333-066FCF1D-6B38-4F92-A9DC-AECB488AD93EQ36081360-386DDB11-AB26-4AAC-A249-B16D445ED235Q36132344-B6854EA5-26B7-4BD0-9794-6C02035F59DFQ36237075-E35D06C0-E268-4BC5-A703-4BC15430A6DCQ36319582-2C427ADB-DAD1-4BC9-AD05-B956E636C05FQ36392832-87DC6D3A-9C71-453C-8B40-A3DC357440E0Q36483712-0729FDCB-8ABE-430C-B18A-139E33A320A7Q36675315-BC6F83C5-A296-47D4-9F34-5C438FD7EDA7Q36821572-37D55B56-0A4F-4EE1-AAA8-E26CD2CDA01CQ36845835-500C185B-7142-4E9D-B9F8-EA8E212709AEQ36865032-14EB8603-B709-4987-B748-F38AEE4A6ED9Q36891034-5F7C5B38-BDC6-45F4-8906-EF02B011C132Q36947101-8E311EC8-503B-4EC5-BBE6-BCCAD486107AQ37000445-14F35CE9-5C99-473C-AC94-11D6F24BADD1Q37068312-622F15E7-2987-4AFC-A986-C60DF1E6D7C7Q37078995-9128728B-8393-4E58-B4D8-8384E7DE7853Q37149721-196C5313-3184-4E4A-B279-B57629859C5CQ37308230-38835B97-00D6-40FD-875F-0B28AC68CF93Q37536440-2951AF7A-3786-4284-844B-01804F33B382Q37557653-1022B24A-8B23-4DE1-9705-1DB096AEAF12Q37738074-AC400B67-00AB-4795-A91A-41B6D54261D7
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Targeting regulatory T cells in cancer
@ast
Targeting regulatory T cells in cancer
@en
Targeting regulatory T cells in cancer
@nl
type
label
Targeting regulatory T cells in cancer
@ast
Targeting regulatory T cells in cancer
@en
Targeting regulatory T cells in cancer
@nl
prefLabel
Targeting regulatory T cells in cancer
@ast
Targeting regulatory T cells in cancer
@en
Targeting regulatory T cells in cancer
@nl
P2093
P2860
P3181
P1433
P1476
Targeting regulatory T cells in cancer
@en
P2093
Gerald C O'Sullivan
James A Lederer
William L Byrne
P2860
P304
P3181
P356
10.1158/0008-5472.CAN-11-1156
P407
P577
2011-11-08T00:00:00Z